Skip to content
PEPTIDE DOSAGESAUSTRALIA
BROWSE THE RESEARCH LIBRARY

Peptide protocol directory.

Find a compound and read its research context before interpreting any chart. Strength, formulation and evidence quality matter more than a number alone.

All 60Single peptides 55Blends 5
Compare research chart

60 research references

A–Z · images shown only for exact matching Peak vials
SINGLE

5-Amino-1MQ

NNMT Inhibitor

50 mg
Research summary · not a validated human regimen
Explore protocol
SINGLE

Adamax

Adamax (N-Acetyl Semax Amidate)

10 mg
Research summary · not a validated human regimen
Explore protocol
SINGLE

Adipotide

FTPP (Fat-Targeted Proapoptotic Peptide)

10 mg
Research summary · not a validated human regimen
Explore protocol
SINGLE

AICAR

5-Aminoimidazole-4-carboxamide Ribonucleotide

50 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia AOD-9604 10 mg vialSINGLEPeak Peptides image

AOD-9604

Anti-Obesity Drug 9604

10 mg
10 mg research vial · no validated preparation or dosing for supplier products
Explore protocol
Peak Peptides Australia ARA-290 10 mg vialSINGLEPeak Peptides image

ARA-290

Cibinetide / EPO-derived 11-residue peptide

10 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia BPC-157 10 mg vialSINGLEPeak Peptides image

BPC-157

Body Protection Compound-157

10 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia Cagrilintide 5 mg vialSINGLEPeak Peptides image

Cagrilintide

Cagrilintide (Long-Acting Amylin Analogue)

5 mg
Investigational · published phase 2 dose-finding study
Explore protocol
SINGLE

Cartalax

Cartalax (Ala-Glu-Asp)

20 mg
Research summary · not a validated human regimen
Explore protocol
SINGLE

CJC-1295 DAC

Modified GRF 1-29 (DAC)

5 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia CJC-1295 No DAC 10 mg vialSINGLEPeak Peptides image

CJC-1295 No DAC

Modified GRF 1-29

10 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia DSIP 10 mg vialSINGLEPeak Peptides image

DSIP

Delta Sleep-Inducing Peptide

10 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia Epithalon 10 mg vialSINGLEPeak Peptides image

Epithalon

Epithalamin Synthetic Analog

10 mg
Research summary · not a validated human regimen
Explore protocol
SINGLE

FOXO4-DRI

FOXO4-D-Retro-Inverso Peptide

10 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia GHK-Cu 50 mg vialSINGLEPeak Peptides image

GHK-Cu

Copper Tripeptide-1

50 mg
Research summary · not a validated human regimen
Explore protocol
SINGLE

GHRP-2

Growth Hormone Releasing Peptide-2

5 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia GHRP-6 10 mg vialSINGLEPeak Peptides image

GHRP-6

Growth Hormone Releasing Peptide-6

10 mg
Research summary · not a validated human regimen
Explore protocol
BLEND

Glow Stack

GHK-Cu (50mg) + BPC-157 (10mg) + TB-500 (10mg)

70 mg
Research summary · not a validated human regimen
Explore protocol
SINGLE

Glutathione

L-Glutathione (Reduced Form / GSH)

600 mg
Research summary · not a validated human regimen
Explore protocol
SINGLE

Gonadorelin

Gonadotropin-Releasing Hormone (GnRH)

2 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia HCG 5000 IU vialSINGLEPeak Peptides image

HCG

Human Chorionic Gonadotropin

5000 IU
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia HGH 191AA 12 IU/vial · 120 IU kit kitSINGLEPeak Peptides image

HGH 191AA

Human Growth Hormone (191 Amino Acid)

12 IU/vial · 120 IU kit

Also 32 IU/vial · 320 IU kit · currently out of stock

IU-labelled research kits · 12 or 32 IU per vial; no validated human kit regimen
Explore protocol
Peak Peptides Australia IGF-1 LR3 1 mg vialSINGLEPeak Peptides image

IGF-1 LR3

Long R3 insulin-like growth factor I (experimental analogue)

1 mg
Experimental analogue · cell and animal evidence; no verified human regimen
Explore protocol
Peak Peptides Australia Ipamorelin 10 mg vialSINGLEPeak Peptides image

Ipamorelin

Selective GH Secretagogue

10 mg
Research summary · not a validated human regimen
Explore protocol
SINGLE

Kisspeptin

Kisspeptin-10 (Metastin)

10 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia KLOW Blend 80 mg vialBLENDPeak Peptides image

KLOW Blend

GHK-Cu (50mg) + BPC-157 (10mg) + TB-500 (10mg) + KPV (10mg)

80 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia KPV 10 mg vialSINGLEPeak Peptides image

KPV

Lysine-Proline-Valine (Alpha-MSH Fragment)

10 mg
Research summary · not a validated human regimen
Explore protocol
SINGLE

L-Carnitine

L-Carnitine (Injectable)

200 mg
Research summary · not a validated human regimen
Explore protocol
SINGLE

Livagen

Livagen (Lys-Glu-Asp-Ala)

20 mg
Research summary · not a validated human regimen
Explore protocol
SINGLE

LL-37

Cathelicidin Antimicrobial Peptide

5 mg
Research summary · not a validated human regimen
Explore protocol
SINGLE

Mazdutide

Mazdutide (LY3305677 / IBI362)

10 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia Melanotan II 10 mg vialSINGLEPeak Peptides image

Melanotan II

Alpha-Melanocyte Stimulating Hormone

10 mg
Research summary · not a validated human regimen
Explore protocol
SINGLE

MGF

Mechano Growth Factor

5 mg
Research summary · not a validated human regimen
Explore protocol
SINGLE

MK-677

Ibutamoren Mesylate

25 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia MOTS-C 10 mg vialSINGLEPeak Peptides image

MOTS-C

Mitochondrial-derived peptide MOTS-c

10 mg

Also available: 20 mg vial

Preclinical research · no validated human research-vial regimen
Explore protocol
Peak Peptides Australia Muscle Blend 10 mg vialBLENDPeak Peptides image

Muscle Blend

CJC-1295 No DAC + Ipamorelin research combination

10 mg
Research blend · no validated combined human regimen
Explore protocol
Peak Peptides Australia NAD+ 1000 mg vialSINGLEPeak Peptides image

NAD+

Nicotinamide Adenine Dinucleotide

1000 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia Oxytocin 10 mg vialSINGLEPeak Peptides image

Oxytocin

Oxytocin (The Bonding Peptide)

10 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia PE-22-28 10 mg vialSINGLEPeak Peptides image

PE-22-28

Spadin-Derived TREK-1 Research Peptide

10 mg
Research summary · not a validated human regimen
Explore protocol
SINGLE

PEG-MGF

PEGylated Mechano Growth Factor

2 mg
Research summary · not a validated human regimen
Explore protocol
SINGLE

Pinealon

Pinealon (Glu-Asp-Arg)

20 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia PNC-27 10 mg vialSINGLEPeak Peptides image

PNC-27

p53-derived chimeric research peptide

10 mg
Preclinical research · no validated human research-vial regimen
Explore protocol
Peak Peptides Australia PT-141 10 mg vialSINGLEPeak Peptides image

PT-141

Bremelanotide

10 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia Retatrutide 10 mg vialSINGLEPeak Peptides image

Retatrutide

Triple Agonist (GLP-1/GIP/Glucagon)

10 mg

Also available: 20 mg vial

Investigational · published human trial
Explore protocol
Peak Peptides Australia Selank 10 mg vialSINGLEPeak Peptides image

Selank

Tuftsin Analog

10 mg
Research summary · not a validated human regimen
Explore protocol
SINGLE

Semaglutide

GLP-1 Receptor Agonist

5 mg
Approved medicine · formulation-specific label
Explore protocol
Peak Peptides Australia Semax 10 mg vialSINGLEPeak Peptides image

Semax

Heptapeptide Analog of ACTH

10 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia Sermorelin 10 mg vialSINGLEPeak Peptides image

Sermorelin

Sermorelin Acetate (GHRH 1-29)

10 mg
Research summary · not a validated human regimen
Explore protocol
BLEND

Shred Stack

AOD-9604 (5mg) + 5-Amino-1MQ (50mg)

55 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia SLU-PP-332 5 mg vialSINGLEPeak Peptides image

SLU-PP-332

Experimental ERR agonist (small molecule, not a peptide)

5 mg
Preclinical small molecule · no established human administration route
Explore protocol
Peak Peptides Australia SS-31 10 mg vialSINGLEPeak Peptides image

SS-31

SS-31 (Elamipretide / Bendavia)

10 mg
Research summary · not a validated human regimen
Explore protocol
SINGLE

Survodutide

Survodutide (BI 456906)

10 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia TB-500 10 mg vialSINGLEPeak Peptides image

TB-500

Thymosin Beta-4 Fragment

10 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia Tesamorelin 10 mg vialSINGLEPeak Peptides image

Tesamorelin

GHRH Analog

10 mg
Research summary · not a validated human regimen
Explore protocol
SINGLE

Testagen

Testagen (Lys-Glu-Asp-Gly)

20 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia Thymosin Alpha-1 10 mg vialSINGLEPeak Peptides image

Thymosin Alpha-1

Thymosin Alpha-1 (Tα1)

10 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia Tirzepatide 10 mg vialSINGLEPeak Peptides image

Tirzepatide

Dual Agonist (GLP-1/GIP)

10 mg
Approved medicine · label context differs from research vials
Explore protocol
SINGLE

Vesugen

Vesugen (Lys-Glu-Asp)

20 mg
Research summary · not a validated human regimen
Explore protocol
SINGLE

Vilon

Vilon (Lys-Glu)

20 mg
Research summary · not a validated human regimen
Explore protocol
Peak Peptides Australia Wolverine Stack 10 mg vialBLENDPeak Peptides image

Wolverine Stack

BPC-157 (5 mg) + TB-500 (5 mg)

10 mg
Research summary · not a validated human regimen
Explore protocol
Product-specific preparation guideConcentration calculatorExplore research articles

The presence of a research entry is not a human-use recommendation. Supplier products marked for in-vitro research must not be treated as interchangeable with approved medicines.